U.S. Enzymes Market Size to Reach USD 9.32 Billion by 2035

U.S. Enzymes Market Size, Share & Trends Analysis Report by 2026-2035

The U.S. Enzymes Market, valued at USD 5.18 billion in 2026, is projected to reach USD 9.32 billion by 2035, growing at a 6.75% CAGR. Driven by rising demand for industrial and specialty enzymes, the market benefits from eco-friendly initiatives and health-conscious consumers. Industrial enzymes dominate, especially in food & beverage, biofuels, and animal feed, while specialty enzymes for pharmaceutical and biotechnology sectors are experiencing rapid growth. Microorganism-derived enzymes lead the market, with increasing applications in drug production, diagnostics, and biocatalysis. Innovations and government support in R&D are poised to drive further expansion in enzyme-based solutions.

Content

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on U.S. Enzymes Market 

5.1. COVID-19 Landscape: U.S. Enzymes Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global U.S. Enzymes Market, By Type

8.1. U.S. Enzymes Market Revenue and Volume, By Type, 2024-2034

8.1.1 Industrial Enzymes

8.1.1.1. Market Revenue and Volume Forecast (2021-2034)

8.1.2. Food & Beverages

8.1.2.1. Market Revenue and Volume Forecast (2021-2034)

8.1.3. Meat Processing

8.1.3.1. Market Revenue and Volume Forecast (2021-2034)

8.1.4. Dairy Products

8.1.4.1. Market Revenue and Volume Forecast (2021-2034)

8.1.5. Beverages

8.1.5.1. Market Revenue and Volume Forecast (2021-2034)

8.1.6. Bakery & Confectionery

8.1.6.1. Market Revenue and Volume Forecast (2021-2034)

8.1.7. Other Food Products

8.1.7.1. Market Revenue and Volume Forecast (2021-2034)

8.1.8. Detergents

8.1.8.1. Market Revenue and Volume Forecast (2021-2034)

8.1.9. Animal Feed

8.1.9.1. Market Revenue and Volume Forecast (2021-2034)

8.1.10. Biofuels

8.1.10.1. Market Revenue and Volume Forecast (2021-2034)

8.1.11. Textiles

8.1.11.1. Market Revenue and Volume Forecast (2021-2034)

8.1.12. Pulp & Paper

8.1.12.1. Market Revenue and Volume Forecast (2021-2034)

8.1.13. Nutraceutical

8.1.13.1. Market Revenue and Volume Forecast (2021-2034)

8.1.14. Personal Care & Cosmetics

8.1.14.1. Market Revenue and Volume Forecast (2021-2034)

8.1.15. Wastewater

8.1.15.1. Market Revenue and Volume Forecast (2021-2034)

8.1.16. Others

8.1.16.1. Market Revenue and Volume Forecast (2021-2034)

8.1.17. Specialty Enzymes

8.1.17.1. Market Revenue and Volume Forecast (2021-2034)

8.1.18. Pharmaceutical

8.1.18.1. Market Revenue and Volume Forecast (2021-2034)

8.1.19. Research & Biotechnology

8.1.19.1. Market Revenue and Volume Forecast (2021-2034)

8.1.20. Diagnostics

8.1.20.1. Market Revenue and Volume Forecast (2021-2034)

8.1.21. Biocatalyst

8.1.21.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 9. Global U.S. Enzymes Market, By Product

9.1. U.S. Enzymes Market Revenue and Volume, By Product, 2024-2034

9.1.1. Carbohydrases

9.1.1.1. Market Revenue and Volume Forecast (2021-2034)

9.1.2. Proteases

9.1.2.1. Market Revenue and Volume Forecast (2021-2034)

9.1.3. Lipases

9.1.3.1. Market Revenue and Volume Forecast (2021-2034)

9.1.4. Polymerases & Nucleases

9.1.4.1. Market Revenue and Volume Forecast (2021-2034)

9.1.5. Others

9.1.5.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 10. Global U.S. Enzymes Market, By Source

10.1. U.S. Enzymes Market Revenue and Volume, by March, 2024-2034

10.1.1. Plants

10.1.1.1. Market Revenue and Volume Forecast (2021-2034)

10.1.2. Animals

10.1.2.1. Market Revenue and Volume Forecast (2021-2034)

10.1.3. Microorganisms

10.1.3.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 11. Global U.S. Enzymes Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Volume Forecast, By Type (2021-2034)

11.1.2. Market Revenue and Volume Forecast, By Product (2021-2034)

11.1.3. Market Revenue and Volume Forecast, By Source(2021-2034)

11.1.4. U.S.

11.1.4.1. Market Revenue and Volume Forecast, By Type (2021-2034)

11.1.4.2. Market Revenue and Volume Forecast, By Product (2021-2034)

11.1.4.3. Market Revenue and Volume Forecast, By Source(2021-2034)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Volume Forecast, By Type (2021-2034)

11.1.5.2. Market Revenue and Volume Forecast, By Product (2021-2034)

11.1.5.3. Market Revenue and Volume Forecast, By Source(2021-2034)

11.2. Europe

11.2.1. Market Revenue and Volume Forecast, By Type (2021-2034)

11.2.2. Market Revenue and Volume Forecast, By Product (2021-2034)

11.2.3. Market Revenue and Volume Forecast, By Source(2021-2034)

11.2.4. UK

11.2.4.1. Market Revenue and Volume Forecast, By Type (2021-2034)

11.2.4.2. Market Revenue and Volume Forecast, By Product (2021-2034)

11.2.4.3. Market Revenue and Volume Forecast, By Source(2021-2034)

11.2.5. Germany

11.2.5.1. Market Revenue and Volume Forecast, By Type (2021-2034)

11.2.5.2. Market Revenue and Volume Forecast, By Product (2021-2034)

11.2.5.3. Market Revenue and Volume Forecast, By Source(2021-2034)

11.2.6. France

11.2.6.1. Market Revenue and Volume Forecast, By Type (2021-2034)

11.2.6.2. Market Revenue and Volume Forecast, By Product (2021-2034)

11.2.6.3. Market Revenue and Volume Forecast, By Source(2021-2034)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Volume Forecast, By Type (2021-2034)

11.2.7.2. Market Revenue and Volume Forecast, By Product (2021-2034)

11.2.7.3. Market Revenue and Volume Forecast, By Source(2021-2034)

11.3. APAC

11.3.1. Market Revenue and Volume Forecast, By Type (2021-2034)

11.3.2. Market Revenue and Volume Forecast, By Product (2021-2034)

11.3.3. Market Revenue and Volume Forecast, By Source(2021-2034)

11.3.4. India

11.3.4.1. Market Revenue and Volume Forecast, By Type (2021-2034)

11.3.4.2. Market Revenue and Volume Forecast, By Product (2021-2034)

11.3.4.3. Market Revenue and Volume Forecast, By Source(2021-2034)

11.3.5. China

11.3.5.1. Market Revenue and Volume Forecast, By Type (2021-2034)

11.3.5.2. Market Revenue and Volume Forecast, By Product (2021-2034)

11.3.5.3. Market Revenue and Volume Forecast, By Source(2021-2034)

11.3.6. Japan

11.3.6.1. Market Revenue and Volume Forecast, By Type (2021-2034)

11.3.6.2. Market Revenue and Volume Forecast, By Product (2021-2034)

11.3.6.3. Market Revenue and Volume Forecast, By Source(2021-2034)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Volume Forecast, By Type (2021-2034)

11.3.7.2. Market Revenue and Volume Forecast, By Product (2021-2034)

11.3.7.3. Market Revenue and Volume Forecast, By Source(2021-2034)

11.4. MEA

11.4.1. Market Revenue and Volume Forecast, By Type (2021-2034)

11.4.2. Market Revenue and Volume Forecast, By Product (2021-2034)

11.4.3. Market Revenue and Volume Forecast, By Source(2021-2034)

11.4.4. GCC

11.4.4.1. Market Revenue and Volume Forecast, By Type (2021-2034)

11.4.4.2. Market Revenue and Volume Forecast, By Product (2021-2034)

11.4.4.3. Market Revenue and Volume Forecast, By Source(2021-2034)

11.4.5. North Africa

11.4.5.1. Market Revenue and Volume Forecast, By Type (2021-2034)

11.4.5.2. Market Revenue and Volume Forecast, By Product (2021-2034)

11.4.5.3. Market Revenue and Volume Forecast, By Source(2021-2034)

11.4.6. South Africa

11.4.6.1. Market Revenue and Volume Forecast, By Type (2021-2034)

11.4.6.2. Market Revenue and Volume Forecast, By Product (2021-2034)

11.4.6.3. Market Revenue and Volume Forecast, By Source(2021-2034)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Volume Forecast, By Type (2021-2034)

11.4.7.2. Market Revenue and Volume Forecast, By Product (2021-2034)

11.4.7.3. Market Revenue and Volume Forecast, By Source(2021-2034)

11.5. Latin America

11.5.1. Market Revenue and Volume Forecast, By Type (2021-2034)

11.5.2. Market Revenue and Volume Forecast, By Product (2021-2034)

11.5.3. Market Revenue and Volume Forecast, By Source(2021-2034)

11.5.4. Brazil

11.5.4.1. Market Revenue and Volume Forecast, By Type (2021-2034)

11.5.4.2. Market Revenue and Volume Forecast, By Product (2021-2034)

11.5.4.3. Market Revenue and Volume Forecast, By Source(2021-2034)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Volume Forecast, By Type (2021-2034)

11.5.5.2. Market Revenue and Volume Forecast, By Product (2021-2034)

11.5.5.3. Market Revenue and Volume Forecast, By Source(2021-2034)

Chapter 12. Company Profiles

12.1. Novozymes

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. DuPont

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. AB Enzyme

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. BASF SE

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. DSM (Koninklijke DSM N.V.)

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Amano Enzymes Inc.

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Kerry Group

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Engrain LLC

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Amano Enzyme

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. AG Scientific

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Share With : linkedin twitter facebook
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034

Meet the Team

Saurabh Bidwai, a B.Tech Chemical Engineering graduate with 4+ years of experience, specializes in specialty chemicals, commodity chemicals, and engineered materials, offering valuable insights into market trends and emerging opportunities.

Learn more about Saurabh Bidwai

Aditi Shivarkar, with 14+ years in Consumer Goods market research, specializes in Consumer Goods. She ensures accurate, actionable insights, driving Towards Consumer Goods excellence in industry trends and sustainability.

Learn more about Aditi Shivarkar
FAQ's

Answer : The U.S. enzymes market size was valued at USD 4.85 billion in 2025, is estimated to reach USD 5.18 billion in 2026, and is projected to reach USD 9.32 billion by 2035, growing at a CAGR of 6.75% from 2026 to 2035.

Answer : USDA and NIH funding for biotechnology and enzyme R&D. EPA support for enzyme use in eco-friendly farming and waste treatment. Incentives for biofuel adoption and sustainable processes. This regulatory support promotes innovation, reduces environmental impact, and strengthens the U.S. position in global enzyme innovation.

Answer : Key growth drivers will be biofuels, pharmaceuticals, sustainable industrial applications, and biotechnology innovations. Companies focusing on eco-friendly solutions, novel enzyme development, and partnerships with pharma & agri-tech players will shape the industry’s future.

Answer : Novozymes, DuPont, AB Enzyme, BASF SE, DSM (Koninklijke DSM N.V.), Amano Enzymes Inc., Kerry Group, Engrain LLC, Amano Enzyme, AG Scientific
Any Questions